Cost effectiveness of interferon in chronic active hepatitis C.
Sallie
R
R
D000375:Aging; D006528:Carcinoma, Hepatocellular / Q000209:etiology; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D006526:Hepatitis C / Q000191:economics* / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000191:economics* / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000191:economics* / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000209:etiology; D012074:Remission Induction
D016898:Interferon-alpha